Medopad
 | |
| Private | |
| Industry | healthcare, big data, small data, mobile, internet of things, pharma, wearables |
| Founded | 2011 |
| Founder | Dan Vahdat and Dr Rich Khatib |
| Headquarters | London, UK |
| Website |
www |
Medopad Ltd is a British healthcare technology company based in London, UK. It also has offices in Salt Lake City, USA, and Dubai, UAE. It produces applications that integrate health data from existing hospital databases as well as patient wearables and other mobile devices and securely transmits it for use by doctors.[1][2]
Products
Enterprise
Medopad allows hospitals to pool their patient data into a single platform so it can be served to doctors' mobile devices in real-time.[3][4] Healthcare professionals can securely access lab results, images, clinical notes, and primary care data via iPads and other mobile devices.[5] In November 2013, Medopad became the first enterprise-class mobile health information system to receive CE approval.[6]
Some of the clinical applications that Medopad include editing patient records by voice recognition or typing, scheduling, lab results, image viewing including X-rays and CT scans, electronic support documents, taking and sending photos, video conferencing, primary records, transmitting real-time vital signs, collecting and managing demographic and contact details, Apple HealthKit integration, and arbitrage system to sort and prioritise patients, hospital admission, and access to more third party applications integrated into Medopad through the Clinical App Store.[1]
Carl Reynolds, head of Open Health Care UK told New Scientist that an open system that worked on multiple devices would be preferential to Medopad as it would avoid locking hospitals into a single system. Medopad will cost hospitals between £50 and £90 per month per user to license.[1]
Cancer
In April 2015, Medopad launched a chemotherapy application for monitoring cancer patients designed specifically for the Apple Watch.[7][8][9][10]
Investors
Some of Medopad's institutional investors are Healthbox and Sandbox Industries.[11][12] Lord Howard Flight and Tony Brown, Non-Executive Director of the NHS both invested individually.[13]
References
- 1 2 3 "NewScientist". Retrieved 16 June 2014.
- ↑ "Journal of mHealth - Real-time clinical information platform driving improved outcomes". Retrieved 30 October 2015.
- ↑ "Financial Times". Retrieved 30 October 2014.
- ↑ "BBC World News Business Edition: Medopad platform technology transforms patient care while improving efficiency and saving cost". Retrieved 30 October 2015.
- ↑ "University of Oxford's Tata Idea Idol Competition". Retrieved 17 June 2014.
- ↑ "Mobile health provider becomes first to receive CE approval". Retrieved 16 June 2014.
- ↑ "The Journal of mHealth". The Journal of mHealth. Retrieved June 4, 2016.
- ↑ "The Lancet Oncology". Retrieved 29 October 2015.
- ↑ "The Stack". Retrieved 29 October 2015.
- ↑ "Bedside manners: Small data from patients at home will mean big cost savings". The Economist. 30 May 2015. Retrieved 29 October 2015.
- ↑ "'Dragons' Den' event promotes innovation in healthcare". Retrieved 17 June 2013.
- ↑ "Company Overview". Retrieved 19 June 2014.
- ↑ "NHS Board of Directors" (PDF). Retrieved 17 June 2014.
Further reading
- Anderson, Elizabeth (December 14, 2014). "App for doctors Medopad valued at £50m in latest funding deal". Telegraph.co.uk. Retrieved June 5, 2016.